These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 4168846)

  • 41. EXPERIENCE IN THE U.S.S.R. IN THE PREVENTION OF MEASLES BY USE OF LIVE VACCINE.
    BOYCHUK LM; SHIKINA ES; MESHALOVA VN; TAROS LY; AMINOVA MG; REVENOK ND; SAFAROV DI
    Ind Med Surg; 1965 Jan; 34():43-50. PubMed ID: 14267212
    [No Abstract]   [Full Text] [Related]  

  • 42. [Influence of measles vaccination using the live measles virus vaccine SSW-L 16 on the complication rate in measles].
    Heidel G; Olbricht H; Ely K; Henkler J
    Z Arztl Fortbild (Jena); 1972 Feb; 66(3):171-4. PubMed ID: 5047088
    [No Abstract]   [Full Text] [Related]  

  • 43. Studies with live attenuated measles-virus vaccine. Comparative clinical, antigenic, and prophylactic effects after inoculation with and without gamma-globulin.
    KRUGMAN S; GILES JP; JACOBS AM; FRIEDMAN H
    Am J Dis Child; 1962 Mar; 103():353-63. PubMed ID: 14459920
    [No Abstract]   [Full Text] [Related]  

  • 44. [First results of measles vaccination in Poland].
    Chrapowicki T; Krauze-Kancewicz B; Azgin W
    Pediatr Pol; 1968 Jul; 43(7):805-11. PubMed ID: 4174896
    [No Abstract]   [Full Text] [Related]  

  • 45. [REPORT OF TEST OF ANTI-MEASLES VACCINATION WITH ATTENUATED LIVING VIRUS].
    CARBONELL JUANICO M; FARRE SOSTRES I; CARDELUS GASSIOT JI; CARBONELL ESTRANY M
    Rev Esp Pediatr; 1963; 19():563-79. PubMed ID: 14094748
    [No Abstract]   [Full Text] [Related]  

  • 46. A study of the protective effect of live measles vaccines 13 to 27 months after vaccination.
    Sejda J; Helcl J; Strauss J; Zdrazílek J; Mírovský J
    J Hyg Epidemiol Microbiol Immunol; 1968; 12(2):187-91. PubMed ID: 5752748
    [No Abstract]   [Full Text] [Related]  

  • 47. Reactions to live-measles-virus vaccine in children previously inoculated with killed-virus vaccine.
    Scott TF; Bonanno DE
    N Engl J Med; 1967 Aug; 277(5):248-50. PubMed ID: 6029312
    [No Abstract]   [Full Text] [Related]  

  • 48. [Specific prevention of measles in Rumania. V. Studies on an attenuated live measles virus vaccine prepared at the Stefan S. Nicolau Institute of Virology and administered in various ways].
    Cajal N; Cepleanu M; Cernesc C; Sorodoc Y; Tigăeru N; Biberi-Moroianu S; Cuciu D; Brebenel G; Vucu E; Petrescu A
    Stud Cercet Virusol; 1973; 24(5):349-56. PubMed ID: 4747453
    [No Abstract]   [Full Text] [Related]  

  • 49. The specific prevention of measles in Romania. Study of a vaccine prepared in human diploid cells.
    Cepleanu M; Cajal N; Cernescu C; Sorodoc Y; Aderca I; Tigăeru N; Suciu D; Manu S; Ferra A; Biberimoroianu S; Dobrescu A; Lucian M
    Rev Roum Virol (1972); 1973; 10(1):8-17. PubMed ID: 4709858
    [No Abstract]   [Full Text] [Related]  

  • 50. Neurological complications following measles vaccination.
    Allerdist H
    Dev Biol Stand; 1979; 43():259-64. PubMed ID: 520673
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Comparative studies of measles vaccines in a controlled trial in the USSR.
    Bolotovskij VM; Nefedova LA; Gelikman BG; Zargaryants AT; Zetilova LP; Nastasina KT
    Bull World Health Organ; 1966; 34(6):859-64. PubMed ID: 5296534
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Measles immune globulin. Proposed standard dose given with liver attenuated measles virus vaccine.
    Warren RJ; Nader PR; Levine RH
    JAMA; 1968 Jan; 203(3):186-8. PubMed ID: 4169348
    [No Abstract]   [Full Text] [Related]  

  • 53. MEASLES VACCINE: RESULTS OF STUDIES WITH BOTH KILLED AND LIVE VIRUS VACCINE.
    RILEY HD
    Memphis Mid South Med J; 1964 Jul; 39():241-51. PubMed ID: 14178142
    [No Abstract]   [Full Text] [Related]  

  • 54. VACCINATION OF INFANTS WITH LIVING ATTENUATED MEASLES VACCINE (EDMONSTON STRAIN) WITH AND WITHOUT GAMMA-GLOBULIN.
    BENSON PF; BUTLER NR; GOFFE AP; KNIGHT GJ; LAURENCE GD; MILLER CL; POLLOCK TM
    Br Med J; 1964 Oct; 2(5413):851-3. PubMed ID: 14185636
    [No Abstract]   [Full Text] [Related]  

  • 55. MEASLES VACCINATION IN SOUTH AFRICA.
    GRASSET N; GEAR JH
    Arch Gesamte Virusforsch; 1965; 16():254-6. PubMed ID: 14322873
    [No Abstract]   [Full Text] [Related]  

  • 56. Immunoglobulins on measles vaccine inoculation or measles virus infection--particularly, on 2-mercaptoethanol sensitive and resistant antibodies.
    Arai M; Nakamura M
    Acta Paediatr Jpn; 1970 Dec; 12(2):9-15. PubMed ID: 4100594
    [No Abstract]   [Full Text] [Related]  

  • 57. MEASLES VACCINATION IN ADULTS WITH AND WITHOUT COMPLICATING CONDITIONS.
    GUDNADOTTIR M; BLACK FL
    Arch Gesamte Virusforsch; 1965; 16():521-3. PubMed ID: 14322927
    [No Abstract]   [Full Text] [Related]  

  • 58. [Indices of humoral antimeasles postvaccinal immunity].
    Tikhonova NT; Prokudina IuA; Khrometskaia TM; Potemkina EE
    Vopr Virusol; 1975; (3):287-92. PubMed ID: 1162947
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Factors affecting the effectiveness of vaccination with live measles vaccine].
    Redechkina ZP
    Pediatriia; 1971 Jan; 50(1):63-5. PubMed ID: 4102318
    [No Abstract]   [Full Text] [Related]  

  • 60. CLINICAL AND SEROLOGICAL OBSERVATIONS ON THE CHILDREN GIVEN ATTENUATED MEASLES VACCINE.
    ARAI M; NAKAMURA M; AKAMATSU T; KIMURA M; KITAYAMA T; KOIDE G
    Acta Paediatr Jpn; 1963 Dec; 14():9-16. PubMed ID: 14200614
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.